thorium has been researched along with Mesothelioma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bjerke, RM; Cruciani, V; Cuthbertson, AS; Ellingsen, C; Golfier, S; Hagemann, UB; Hennekes, H; Karlsson, J; Kneip, C; Kristian, A; Mobergslien, A; Mumberg, D; Ryan, OB; Schatz, CA; Schuhmacher, J; Smeets, R; Uran, S; Wickstroem, K; Ziegelbauer, K | 1 |
1 other study(ies) available for thorium and Mesothelioma
| Article | Year |
|---|---|
Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers.
Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Evaluation, Preclinical; Female; GPI-Linked Proteins; Humans; Immunoconjugates; Lung Neoplasms; Mesothelin; Mesothelioma; Mesothelioma, Malignant; Mice; Mice, Nude; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Radiopharmaceuticals; Thorium; Tissue Distribution; Xenograft Model Antitumor Assays | 2019 |